Savid Therapeutics Inc.
Records under this name other than the patents Savid Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Savid Therapeutics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,546,537 | Streptavidin Having Low Immunogenicity and Use Thereof now held by Complecure, Inc. In force · High confidence | In force | High confidence | |
| US 9,670,255 | Modified Biotin, Mutant Streptavidin, and Use Thereof now held by Complecure, Inc. In force · High confidence | In force | High confidence | |
| US 11,286,285 | Modified Biotin, Streptavidin Mutant, and Usage of Them now held by Complecure, Inc. In force · High confidence | In force | High confidence | |
| US 11,161,884 | Modified Biotin, Streptavidin Mutant, and Usage of Them now held by Complecure, Inc. In force · High confidence | In force | High confidence | |
| US 12,115,223 | Conjugate of Biotin-Modified Dimer and Phthalocyanine Dye now held by Complecure, Inc. In force · High confidence | In force | High confidence | |
| US 12,721,903 | Conjugate of Phthalocyanine Dye and Antibody or Peptide now held by Complecure, Inc. In force · High confidence | In force | High confidence | |
| US 11,442,066 | Method for Identifying Drug-Discovery Target Protein for Development of Antibody Drug, and Method for Producing Antibody Against Target Protein held by Mitsui Chemicals, Inc., National Institutes of Biomedical Innovation, Health and Nutrition and Savid Therapeutics Inc. Lapsed on the fee record Ended Sep 13, 2026 · High confidence | Lapsed on the fee record | Ended Sep 13, 2026 | High confidence |
| 16/623,504 | Anti-Sulfated Glycosaminoglycan Antibody Abandoned Abandoned Mar 28, 2024 | Abandoned | Abandoned Mar 28, 2024 | |
| 17/042,534 | Use of Bis-Iminobiotin Compound for Drug Delivery Purposes Abandoned Abandoned Jun 22, 2023 | Abandoned | Abandoned Jun 22, 2023 | |
| 17/059,334 | Halogenated Biotin-Modified Dimer and Use Thereof held by The University of Tokyo and Savid Therapeutics Inc. Abandoned Abandoned Mar 23, 2024 | Abandoned | Abandoned Mar 23, 2024 |